These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2241006)

  • 1. [A multicenter double blind versus placebo study of trimetazidine in tinnitus. Results obtained after 2 months of treatment].
    Morgon A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():77-81. PubMed ID: 2241006
    [No Abstract]   [Full Text] [Related]  

  • 2. [A multicenter double blind versus placebo study of trimetazidine in tinnitus. Methods].
    Lacomme Y
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():71-2. PubMed ID: 2241004
    [No Abstract]   [Full Text] [Related]  

  • 3. [A multicenter double blind versus placebo study of trimetazidine in tinnitus. Measurements of tinnitus].
    Labaeye P; Wayoff M
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():68-70. PubMed ID: 2241002
    [No Abstract]   [Full Text] [Related]  

  • 4. [A multicenter double blind versus placebo study of trimetazidine in tinnitus. Epidemiologic analysis of the results].
    Bebear JP
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():73-6. PubMed ID: 2241005
    [No Abstract]   [Full Text] [Related]  

  • 5. [A multicenter double blind versus placebos study of trimetazidine in tinnitus. A clinical approach to tinnitus].
    Pech A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():66-7. PubMed ID: 2241001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The efficacy of trimetazidine in cochleovestibular disorders of ischemic origin. A crossover control versus placebo trial].
    Coyas A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():82-7. PubMed ID: 2241007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the therapeutic efficacy of vastarel 20 mg (trimetazidine) in cochleovestibular syndromes. A double-blind study versus placebo].
    Wayoff M
    Ann Otolaryngol Chir Cervicofac; 1984; 101(7):565-9. PubMed ID: 6391338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
    Lévy S
    Ann Cardiol Angeiol (Paris); 1995 Apr; 44(4):203-12. PubMed ID: 7632029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimetazidine: a second look. Just a placebo.
    Prescrire Int; 2000 Feb; 9(45):207-9. PubMed ID: 11503798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trimetazidine and degenerative deafness. Effect on hearing and integration].
    Haguenauer JP; Bebear JP; Bordes LR; Jacquot M; Mercier J; Morgon A; Pech A; Romanet P; Thomassin JM; Wayoff M
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():51-6. PubMed ID: 2240999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study].
    Sellier P
    Arch Mal Coeur Vaiss; 1986 Aug; 79(9):1331-6. PubMed ID: 3101636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trimetazidine (Vastarel 20 mg) and electro-acoustic stimulation in the treatment of tinnitus. Apropos of 64 cases].
    Desaulty A; Gelaude A
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():57-64. PubMed ID: 2241000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials.
    Rejali D; Sivakumar A; Balaji N
    Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):226-31. PubMed ID: 15142066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.
    Westerberg BD; Roberson JB; Stach BA
    Am J Otol; 1996 Nov; 17(6):896-903. PubMed ID: 8915419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the administration of trimetazidine associated with hemodilution in the treatment of sudden deafness. Report of a multicenter study].
    Beutter P; Guinard F; Jalbert D; Marsac A; Morin R; Sauvage JP; Soudant J
    Ann Otolaryngol Chir Cervicofac; 1990; 107(5):345-50. PubMed ID: 2221729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of trimetazidine in the long-term treatment of cardiomyopathies of ischemic origin].
    Brottier L; Barat JL; Combe C; Boussens B; Bonnet J; Bricaud H
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):179-82. PubMed ID: 2735733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.
    Moller AR
    Am J Otol; 1997 Mar; 18(2):268-9. PubMed ID: 9093691
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of the combination of trimetazidine and a calcium inhibitor in the treatment of chronic coronary insufficiency. Double-blind controlled study versus placebo].
    Brochier M; Demange J; Ducloux G; Monpère C; Warin JF
    Ann Cardiol Angeiol (Paris); 1986 Jan; 35(1):49-56. PubMed ID: 3516053
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
    Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
    Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.